Company:Replenish Nutrients
Listings: CSE Canada , Frankfurt and US OTC
Tickers: ERTH / VVIVF / WIMN
Market cap at time of publication: $21 MCAD
Stock price at time of publication: $0.13 CAD
Business: Regenerative agriculture
Website:https://replenishnutrients.com/
Target price: CAD 0.44 (USD 0.31)
Sweden, March 31st, 2026
Replenish Nutrients’ completion of its oversubscribed $4.8M CAD private placement marks a big step in strengthening its balance sheet as the company moves into a more execution-driven growth phase. In a tight financing environment, raising capital across multiple tranches—and including ~$1.35M CAD in debt settlement—signals both investor support and improved financial positioning for the company.
CEO Neil Wiens emphasized the operational inflection point ahead: “This capital strengthens our working capital position as we continue scaling production at our Beiseker facility and advancing our licensing partnerships with MJ Ag and Farmers Union… we believe Replenish is well positioned to execute on the next phase of growth in 2026.”
From an investor standpoint, this financing stands out for a few reasons. First, proceeds are clearly tied to production ramp-up and partner execution, not early-stage validation—suggesting the focus is now on throughput and revenue generation. Second, the inclusion of a strategic investment structure with Sorbie Bornholm LP, which introduces potential monthly cash inflows linked to share performance, adds a non-dilutive-like component that could support liquidity over time.
Importantly, the company is aligning capital with catalysts:
-Beiseker facility moving toward steady-state operations
-Licensing partners progressing toward commissioning
-Focus on increasing production volumes and adoption
Taken together, this financing reduces near-term funding risk while positioning Replenish Nutrients to convert existing partnerships into revenue. For investors, this represents a shift from story-driven valuation to execution and cash flow visibility, which is typically where re-rating potential begins to emerge. ESGFIRE has a buy rating on Replenish Nutrients and a target price ofCAD 0.44 (USD 0.31) for 2026.
ESGFIRE is a Swedish investment company and research firm that focuses on companies with either an environmentally friendly service or product. By only investing in environmentally friendly companies, ESGFIRE have outperformed the major indexes for several years. We have a track record of over 1000 % returns since 2018 using our own proven method of identifying high potential ESG companies.
Contact details
Website: www.esgfire.com
CEO: Filip Erhardt
Email: Filip@esgfire.com
Telephone:+46701609605
Legal Disclaimer
This interview is based upon reliable sources, namely regulated press releases from the company and investor presentations. Nevertheless, this interview may contain interpretations, estimates, or opinions of the authors, or other non-factual information. If that is the case, this is continuously stated above. Furthermore, any projections, forecasts, or similar are explicitly stated as such. The author holds shares and/or other securities of this company and the relevant company may or may not have paid the author for this content. . Because of the above, ESGFIRE urges the readers to always analyze all materials critically in an objective manner, e.g., concerning the reliability of the relevant source and of what constitutes the authors’ personal interpretations. The readers is hereby reminded that the post does, as set forth in the Post, contain interpretations, estimates, or opinions of the authors. This interview was published by Filip Erhardt, at ESGFIRE on 31/3 2026. Investing in stocks is combined with certain risks and it is possible to lose your entire investment. Our posts are made for educational purposes only and are not to be interpreted as tips, financial advice or recommendations of any kind to either buy or sell any stocks.
Furthermore, this interview is produced and distributed as general investment research intended for broad public dissemination. It does not take into account the specific investment objectives, financial situation or particular needs of any individual investor.
Any price targets, valuations, or similar forward-looking assessments are based on publicly available information and the author’s own methodology, and should be understood strictly as opinions, not as personal recommendations.
This material shall not be construed as personal investment advice under MiFID II or Swedish law. Readers are strongly encouraged to make their own investment decisions independently or seek advice from a licensed financial adviser.
